|Articles|October 14, 2022
- Applied Clinical Trials-10-01-2022
- Volume 31
- Issue 10
Applied Clinical Trials October 2022 Issue (PDF)
Advertisement
Articles in this issue
almost 4 years ago
Managing Biospecimens in Cell and Gene Therapy Trialsalmost 4 years ago
The Risk-Reward Proposition for CGT Clinical Trialsalmost 4 years ago
Philadelphia Shines in Cell and Gene Therapy Research Pursuitsalmost 4 years ago
Survey Investigates Backup Solution Adoption for ePRO Systemsalmost 4 years ago
Scientists Don’t Ever Stop Sciencingalmost 4 years ago
Key Clinical Trial Industry Themes Post-COVIDAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5
